Table 3.
Summary of human genetic factors associated with Hodgkin’s lymphoma
| Potential risk factor | Summary of results |
|---|---|
|
HLA and associated genes: | |
|
HLA-A |
A*01 associated with increased risk, A*02 with decreased risk [36] |
| A*01:01 associated with increased risk [41] |
|
|
HLA-B |
B*08:01 associated with increased risk [41] |
| B*07 and B*08 no association [29] |
|
|
HLA region |
Locus D6S265 allele 126 and locus D6S510 allele 284 heterozygotes and homozygotes (both HLA class I) associated with HL risk in a classic association analysis. (Other, weaker, associations also found.) Association lost when haplotype sharing statistic analysed [35]. Later narrowed down as above [36]. |
| HLA class I associated through seven SNPs – rs2530388, rs3823352, rs2256543, rs4713276, rs2523972, rs6457110, rs2517749 [76]. Later narrowed down as above [36]. |
|
| C*07:01 and DRB1*03:01 associated with increased risk [41] |
|
| Genome-wide association study: rs6904029 (HCG9) associated with decreased risk or rs2734986 (HLA-G) associated with increased risk [34] |
|
| rs6457715, near HLA-DPB1, associated with increased risk [30] |
|
|
Cytokines and chemokines: | |
|
TNFA, TNFB |
No association [35] |
|
Other immune-related: | |
| KIR | No clear association [52] |
HL – Hodgkin’s lymphoma, HLA – human leukocyte antigen, KIR – killer-cell immunoglobulin-like receptors, SNP – single nucleotide polymorphism, TNF – tumour necrosis factor